-
FDA approves AstraZeneca lung cancer drug
Imfinzi, a drug manufactured by AstraZeneca, has been approved by the FDA for treatment of early-stage, non-small cell lung cancer in combination with chemotherapy. -
Rhode Island system pivots after oncologists resign
Wakefield, R.I.-based South County Health experienced a staffing shake-up this summer after three hematology oncology providers resigned due to "chronic underfunding." -
7 organizations to use $150M to reimagine cancer surgery
Seven health organizations are using Cancer Moonshot funds to reimagine and advance cancer surgery, Politico reported Aug. 14. -
Patient-reported outcome measures improve cancer patients' survival: Study
Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. -
Biden commits $150M to cancer research
The Biden administration will dole out up to $150 million in research funding awards as part of its Cancer Moonshot initiative. -
Alabama hospital converts COVID unit back to cancer beds
Tuscaloosa, Ala.-based DCH Regional Medical Center is reopening the hospital's oncology unit, WVUA 23 reported Aug. 12. -
95 oncologists on the move in 2024
Here are 95 oncologists and oncology leaders stepping into new roles in 2024: -
Men's cancer deaths to increase 93% by 2050: Study
Global cancer deaths among men are projected to increase more than 93% from 5.4 million in 2022 to 10.5 million in 2050, according to a study published Aug. 12 in the American Cancer Society journal Cancer. -
'There is real purpose here': Dr. Eileen Hacker on bolstering nurse research at MD Anderson
When Eileen Hacker, PhD, APRN, was overcome with emotion upon being inducted into the International Nurse Researcher Hall of Fame. When reached by Becker's, she called it an honor and a privilege. -
Cannabis raises risk of head, neck cancers: Study
Cannabis users are 3.5 to five times more likely to develop head and neck cancers, a recent Los Angeles-based Keck Medicine of USC study found. -
Heart disease, cancer remain leading causes of death in US
Heart disease and cancer remained the leading causes of death in 2023, according to provisional data released Aug. 8 by the CDC. -
McLaren cyberattack delayed cancer treatment for some patients
Patients at Karmanos Cancer Institute at McLaren Flint (Mich.) are experiencing disruptions in care after a cyberattack on the system, ABC affiliate WXYZ reported Aug. 8. -
Radiotherapy lowers breast cancer recurrence: Study
Radiotherapy significantly lowers breast tumor recurrence but has little effect on survival, according to a long-term study published Aug. 7 in The Lancet Oncology. -
HHS awards $8.9M to improve cancer screening access
HHS has awarded almost $9 million to 18 health centers across the country. -
New cancer center to open in Indiana
Munster, Ind.-based health system Powers Health and Dyer, Ind.-based oncology group Northwest Cancer Centers have partnered to open a new cancer center. -
11 cancer centers ranked by readmissions
Only four cancer hospitals have an unplanned readmission rate for cancer patients below the national average, according to CMS data. -
How cancer screenings are shaking up physician workloads
Recently, the recommended screening age for two cancers dropped, which could impact oncologist workloads. -
NYU Langone names new surgical oncology chief
New York City-based NYU Langone Health has named Gary Deutsch, MD, chief of the surgical oncology division at NYU Grossman Long Island School of Medicine. -
Fox Chase names chief of new breast surgery division
Fox Chase Cancer Center in Philadelphia has promoted Richard Bleicher, MD, to chief of the center's new breast surgery division. -
Cancer screening costs hit $43B in 2021: Study
The total U.S. healthcare system costs for initial cancer screenings in 2021 were an estimated $43 billion, according to a study published Aug. 5 in The Annals of Internal Medicine.
Page 10 of 50